184
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

The effect of pentoxifylline on cerebral vasospasm following experimental subarachnoid hemorrhage

ORCID Icon, , , , &
Pages 909-913 | Received 09 Oct 2018, Accepted 01 Apr 2020, Published online: 03 May 2020

References

  • Atalay B, Caner H, Çekinmez M, et al. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery. 2006;59(5):1102–1108.
  • Treggiari-Venzi MM, Suter PM, Romand J-A. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery. 2001;48(2):249–261.
  • Gross BA, Lai PMR, Frerichs KU, et al. Treatment modality and vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2014;82(6):e275–30.
  • Song JN, An JY, Hao G-S, et al. Role of Akt signaling pathway in delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Acta Neurochir. 2013;155(11):2063–2070.
  • Biller J, Godersky JC, Adams HP. Jr. HPA. Management of aneurysmal subarachnoid hemorrhage. Stroke. 1988;19(10):1300–1305.
  • Eğin S, İlhan M, Bademler S, et al. Protective effects of pentoxifylline in small intestine after ischemia–reperfusion. J Int Med Res. 2018;46(10):4140–4156.
  • Vakili A, Mojarrad S, Akhavan MM, et al. Rashidy-Pour A. Pentoxifylline attenuates TNF-α protein levels and brain edema following temporary focal cerebral ischemia in rats. Brain Res. 2011;1377:119–125.
  • An ZM, Dong X-G, Guo Y, et al. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy. J Huazhong Univ Sci Technol [Med Sci]. 2015;35(3):356–361.
  • Festing MF. Design and statistical methods in studies using animal models of development. ILAR J. 2006;47(1):5–14.
  • Garzon-Muvdi T, Pradilla G, Ruzevick JJ, et al. A glutamate receptor antagonist, S-4-Carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected]. Neurosurgery. 2013;73(4):719–728.
  • Schebesch KM, Herbst A, Bele S, et al. Calcitonin-gene related peptide and cerebral vasospasm. J Clin Neurosci. 2013;20(4):584–586.
  • Sehba FA, Schwartz AY, Chereshnev I, et al. Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2000;20(3):604–611.
  • Clatterbuck RE, Gailloud P, Tierney T, et al. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg. 2005;103(4):745–751.
  • Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105(1):23–56.
  • Saber H, Desai A, Palla M, et al. Efficacy of cilostazol in prevention of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: A meta-analysis. J Stroke Cerebrovasc Dis. 2018;27:2979–2985.
  • Fujii M, Yan J, Rolland WB, et al. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res. 2013;4(4):432–446.
  • Zhang L, Coombes J, Pascoe EM, et al. The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial. Redox Rep. 2016;21(1):14–23.
  • Nouri M, Movassaghi S, Foroumadi A, et al. Protective effect of pentoxifylline on male Wistar rat testicular germ cell apoptosis induced by 3,4-methylenedioxymeth amphetamine. Iran J Basic Med Sci. 2016;19(6):646–652.
  • Inoha S, Inamura T, Ikezaki K, et al. Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model. Neurol Res. 2002;24(6):607–612.
  • Sobey CG. Cerebrovascular dysfunction after subarachnoid haemorrhage: Novel mechanisms and directions for therapy. Clin Exp Pharmacol Physiol. 2001;28(11):926–929.
  • Kalay S, Oztekin O, Tezel G, et al. The effects of intraperitoneal pentoxifylline treatment in rat pups with hypoxic-ischemic encephalopathy. Pediatr Neurol. 2013;49(5):319–323.
  • Kreth S, Ledderose C, Luchting B, et al. Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways. Shock. 2010;34(1):10–16.
  • Goksu E, Dogan O, Ulker P, et al. Pentoxifylline alleviates early brain injury in a rat model of subarachnoid hemorrhage. Acta Neurochir. 2016;158(9):1721–1730.
  • Xia DY, Zhang HS, Wu LY, et al. Pentoxifylline alleviates early brain injury after experimental subarachnoid hemorrhage in rats: Possibly via inhibiting TLR 4/NF-κB signaling pathway. Neurochem Res. 2017;42(4):963–974.
  • Bilginer B, Önal MB, Narin F, et al. The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model. Turk Neurosurg. 2009;19(4):374–379.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.